Literature DB >> 3441508

Photodynamic therapy-induced hypoxia in rat tumors and normal tissues.

B D Hirsch, N C Walz, B E Meeker, M R Arnfield, J Tulip, M S McPhee, J D Chapman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3441508     DOI： 10.1111/j.1751-1097.1987.tb04858.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN： 0031-8655            Impact factor:   3.421


× No keyword cloud information.
  6 in total

Review 1.  Fighting Hypoxia to Improve PDT.

Authors:  Ludivine Larue; Bauyrzhan Myrzakhmetov; Amina Ben-Mihoub; Albert Moussaron; Noémie Thomas; Philippe Arnoux; Francis Baros; Régis Vanderesse; Samir Acherar; Céline Frochot
Journal:  Pharmaceuticals (Basel)       Date:  2019-10-30

2.  Non-invasive monitoring of photodynamic therapy with 99technetium HMPAO scintigraphy.

Authors:  R B Moore; J D Chapman; A D Mokrzanowski; M R Arnfield; M S McPhee; A J McEwan
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

3.  The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro.

Authors:  L Wyld; M W Reed; N J Brown
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

4.  Increasing the effect of photodynamic therapy on the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145.

Authors:  J C Bremner; G E Adams; J K Pearson; J M Sansom; I J Stratford; J Bedwell; S G Bown; A J MacRobert; D Phillips
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

5.  Anti-tumour activity of photodynamic therapy in combination with mitomycin C in nude mice with human colon adenocarcinoma.

Authors:  L W Ma; J Moan; H B Steen; V Iani
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

6.  Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy.

Authors:  I P van Geel; H Oppelaar; P F Rijken; H J Bernsen; N E Hagemeier; A J van der Kogel; R J Hodgkiss; F A Stewart
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.